Cite
Polzin A, Dannenberg L, Helten C, et al. Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study. J Am Heart Assoc. 2021;10(22):e022299doi: 10.1161/JAHA.121.022299.
Polzin, A., Dannenberg, L., Helten, C., Pöhl, M., Metzen, D., Mourikis, P., Dücker, C., Marschall, U., L'Hoest, H., Hennig, B., Zako, S., Trojovsky, K., Petzold, T., Jung, C., Levkau, B., Zeus, T., Schrör, K., Hohlfeld, T., Kelm, M., Scholar, H., & McLaughlin, H. (2021). Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study. Journal of the American Heart Association, 10(22), e022299. https://doi.org/10.1161/JAHA.121.022299
Polzin, Amin, et al. "Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study." Journal of the American Heart Association vol. 10,22 (2021): e022299. doi: https://doi.org/10.1161/JAHA.121.022299
Polzin A, Dannenberg L, Helten C, Pöhl M, Metzen D, Mourikis P, Dücker C, Marschall U, L'Hoest H, Hennig B, Zako S, Trojovsky K, Petzold T, Jung C, Levkau B, Zeus T, Schrör K, Hohlfeld T, Kelm M, Scholar H, McLaughlin H. Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study. J Am Heart Assoc. 2021 Nov 16;10(22):e022299. doi: 10.1161/JAHA.121.022299. Epub 2021 Nov 02. PMID: 34726072.
Copy
Download .nbib